Literature DB >> 28884984

Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy.

Jesús Romero-Imbroda1, Teresa Sagrario-Fustero2, Clementina Del Canto-Pérez3.   

Abstract

Entities:  

Year:  2017        PMID： 28884984      PMCID： PMC5653640          DOI： 10.3988/jcn.2017.13.4.444

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN： 1738-6586            Impact factor:   3.077


× No keyword cloud information.
  8 in total

1.  Transthyretin-type cerebral amyloid angiopathy: a serious complication in post-transplant patients with familial amyloid polyneuropathy.

Authors:  Yoshiki Sekijima
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-11       Impact factor: 10.154

Review 2.  Liver transplantation and transthyretin amyloidosis.

Authors:  Merrill D Benson
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

Review 3.  Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment.

Authors:  E Hund; R P Linke; F Willig; A Grau
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

4.  Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment.

Authors:  Merrill D Benson; Richard A Smith; Gene Hung; Barbara Kluve-Beckerman; Aaron D Showalter; Kyle W Sloop; Brett P Monia
Journal:  Amyloid       Date:  2010-06       Impact factor: 7.141

5.  Progression of transthyretin amyloid neuropathy after liver transplantation.

Authors:  Juris J Liepnieks; Lucy Q Zhang; Merrill D Benson
Journal:  Neurology       Date:  2010-07-27       Impact factor: 9.910

6.  Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis.

Authors:  Yoshiki Sekijima; Masahide Yazaki; Kazuhiro Oguchi; Naoki Ezawa; Tsuneaki Yoshinaga; Mitsunori Yamada; Hiroyuki Yahikozawa; Masahide Watanabe; Fuyuki Kametani; Shu-Ichi Ikeda
Journal:  Neurology       Date:  2016-07-27       Impact factor: 9.910

7.  Familial amyloid polyneuropathy: a clinico-pathologic study.

Authors:  Gérard Said; Violaine Planté-Bordeneuve
Journal:  J Neurol Sci       Date:  2009-05-24       Impact factor: 3.181

8.  Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy.

Authors:  Teresa Coelho; Luis F Maia; Ana Martins da Silva; Márcia W Cruz; Violaine Planté-Bordeneuve; Ole B Suhr; Isabel Conceiçao; Hartmut H-J Schmidt; Pedro Trigo; Jeffery W Kelly; Richard Labaudinière; Jason Chan; Jeff Packman; Donna R Grogan
Journal:  J Neurol       Date:  2013-08-22       Impact factor: 4.849
  8 in total
  2 in total

1.  Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation.

Authors:  Catherine Bulinski; Thomas Discher; Wiebke Rutsatz; Birgit Assmus; Heidrun H Krämer
Journal:  J Neurol       Date:  2022-02-06       Impact factor: 6.682

2.  Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation.

Authors:  Hartmut H Schmidt; Jonas Wixner; Violaine Planté-Bordeneuve; Francisco Muñoz-Beamud; Laura Lladó; Julian D Gillmore; Anna Mazzeo; Xingyu Li; Seth Arum; Patrick Y Jay; David Adams
Journal:  Am J Transplant       Date:  2022-03-26       Impact factor: 9.369
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.